Veradermics, Inc (MANE) stock
MANENYSEPharmaceutical PreparationsFiscal year ends December 31
$135.29−21.27 (-13.59%)
Close on Nov 12, 2026Market cap $5.65BP/E –Yield –
Veradermics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Veradermics's enterprise value was $5.72B on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.72B | – |
See a number that looks wrong?